Potent and Sustained Antiviral Response of Raltegravir-based Highly Active Antiretroviral Therapy in HIV Type 1-infected Children and Adolescents-Reference-Cited by-同舟云学术

Potent and Sustained Antiviral Response of Raltegravir-based Highly Active Antiretroviral Therapy in HIV Type 1-infected Children and Adolescents

Published:2012-03 Issue:3 Volume:31 Page:273-277
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Briz Verónica,León-Leal Juan A.,Palladino Claudia,Moreno-Perez David,de Ory Santiago J.,De José Ma Isabel,González-Tomé Ma Isabel,Martín César Gavilán,Pocheville Itziar,Ramos José T.,Leal Manuel,Muñoz-Fernández Ma Ángeles

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference7 articles.

1. . Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.;Hazuda;Science,2000

2. . Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.;Steigbigel;Clin Infect Dis,2010

3. . Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.;Lennox;Lancet,2009

4. . The Spanish HIV BioBank: a model of cooperative HIV research.;Garcia-Merino;Retrovirology,2009

5. Management of paediatric HIV-1 resistance.;Gupta;Curr Opin Infect Dis,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrase Strand Transfer Inhibitor Use in Children with Perinatal HIV-1 Infection: A Narrative Review;AIDS Research and Human Retroviruses;2023-01-06

2. Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review;Journal of the International AIDS Society;2022-11

3. HIV-Infektion im Kindesalter – Update;Pädiatrie & Pädologie;2019-01-14

4. Specific Patterns of T Cell Immunosenescence in Vertically HIV-Infected Subjects;Handbook of Immunosenescence;2019

5. Characteristics and early outcomes of children and adolescents treated with darunavir/ritonavir-, raltegravir- or etravirine-containing antiretroviral therapy in the Western Cape Province of South Africa;South African Medical Journal;2018-02-01